UBS Group AG - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 129 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$741,054
-41.1%
58,259
-34.8%
0.00%
Q2 2023$1,258,639
-14.6%
89,392
-6.3%
0.00%
-100.0%
Q1 2023$1,473,868
-46.9%
95,396
-43.7%
0.00%0.0%
Q4 2022$2,775,483
+266.2%
169,340
+313.6%
0.00%
Q3 2022$758,000
-44.3%
40,943
-60.5%
0.00%
-100.0%
Q2 2022$1,362,000
-64.3%
103,554
-74.9%
0.00%0.0%
Q1 2022$3,819,000
-12.4%
411,978
-7.7%
0.00%0.0%
Q4 2021$4,361,000
+319.3%
446,379
+1358.9%
0.00%
Q3 2021$1,040,000
+178.8%
30,596
+200.1%
0.00%
Q2 2021$373,000
-79.8%
10,195
-75.2%
0.00%
-100.0%
Q1 2021$1,842,000
+48.0%
41,061
+88.3%
0.00%
Q4 2020$1,245,000
+24.5%
21,807
+11.9%
0.00%
Q3 2020$1,000,000
+17.0%
19,484
+36.1%
0.00%
Q2 2020$855,000
+606.6%
14,312
+386.0%
0.00%
Q1 2020$121,000
-80.6%
2,945
-70.7%
0.00%
Q4 2019$625,000
-67.7%
10,054
-82.3%
0.00%
-100.0%
Q3 2019$1,933,000
+695.5%
56,929
+429.2%
0.00%
Q2 2019$243,000
+33.5%
10,757
+37.4%
0.00%
Q1 2019$182,000
-82.3%
7,830
-84.1%
0.00%
Q4 2018$1,031,000
+410.4%
49,103
+842.3%
0.00%
Q3 2018$202,000
-19.2%
5,211
-17.8%
0.00%
Q2 2018$250,000
+166.0%
6,339
+35.4%
0.00%
Q1 2018$94,000
-6.0%
4,680
+6.2%
0.00%
Q4 2017$100,0004,4070.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders